IRAK-M Mediates Toll-like Receptor/il-1R-induced NFκB Activation and Cytokine Production
Hao Zhou,Minjia Yu,Koichi Fukuda,Jinteak Im,Peng Yao,Wei Cui,Katarzyna Bulek,Jarod Zepp,Youzhong Wan,Tae Whan Kim,Weiguo Yin,Victoria Ma,James Thomas,Jun Gu,Jian-an Wang,Paul E. DiCorleto,Paul L. Fox,Jun Qin,Xiaoxia Li
DOI: https://doi.org/10.1038/emboj.2013.2
2013-01-01
Abstract:Toll-like receptors transduce their signals through the adaptor molecule MyD88 and members of the IL-1R-associated kinase family (IRAK-1, 2, M and 4). IRAK-1 and IRAK-2, known to form Myddosomes with MyD88-IRAK-4, mediate TLR7-induced TAK1-dependent NFκB activation. IRAK-M was previously known to function as a negative regulator that prevents the dissociation of IRAKs from MyD88, thereby inhibiting downstream signalling. However, we now found that IRAK-M was also able to interact with MyD88-IRAK-4 to form IRAK-M Myddosome to mediate TLR7-induced MEKK3-dependent second wave NFκB activation, which is uncoupled from post-transcriptional regulation. As a result, the IRAK-M-dependent pathway only induced expression of genes that are not regulated at the post-transcriptional levels (including inhibitory molecules SOCS1, SHIP1, A20 and IκBα), exerting an overall inhibitory effect on inflammatory response. On the other hand, through interaction with IRAK-2, IRAK-M inhibited TLR7-mediated production of cytokines and chemokines at translational levels. Taken together, IRAK-M mediates TLR7-induced MEKK3-dependent second wave NFκB activation to produce inhibitory molecules as a negative feedback for the pathway, while exerting inhibitory effect on translational control of cytokines and chemokines.